Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 18  •  10:48AM ET
6.77
Dollar change
+0.11
Percentage change
1.65
%
Index- P/E- EPS (ttm)-0.69 Insider Own19.66% Shs Outstand19.62M Perf Week-1.60%
Market Cap153.37M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float13.92M Perf Month-39.98%
Enterprise Value162.24M PEG- EPS next Q-0.10 Inst Own1.49% Short Float0.34% Perf Quarter-26.76%
Income-11.89M P/S4.69 EPS this Y22.61% Inst Trans10.18% Short Ratio0.59 Perf Half Y8.49%
Sales32.72M P/B17.17 EPS next Y90.39% ROA-38.97% Short Interest0.05M Perf YTD9.55%
Book/sh0.39 P/C13.98 EPS next 5Y- ROE-200.22% 52W High12.80 -47.11% Perf Year15.73%
Cash/sh0.48 P/FCF- EPS past 3/5Y-0.33% 45.00% ROIC-54.04% 52W Low4.72 43.32% Perf 3Y-9.53%
Dividend Est.- EV/EBITDA- Sales past 3/5Y128.83% 158.55% Gross Margin59.21% Volatility20.73% 14.02% Perf 5Y54.74%
Dividend TTM- EV/Sales4.96 EPS Y/Y TTM43.12% Oper. Margin-18.77% ATR (14)1.14 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.02 Sales Y/Y TTM45.88% Profit Margin-36.33% RSI (14)35.80 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.35 EPS Q/Q7.03% SMA20-22.73% Beta1.31 Target Price13.67
Payout- Debt/Eq2.56 Sales Q/Q38.66% SMA50-29.93% Rel Volume1.47 Prev Close6.66
Employees87 LT Debt/Eq1.84 EarningsNov 13 AMC SMA200-9.14% Avg Volume80.09K Price6.77
IPOMar 08, 2019 Option/ShortNo / Yes EPS/Sales Surpr.-21.74% -0.48% Trades Volume28,325 Change1.65%
Date Action Analyst Rating Change Price Target Change
May-05-25Initiated Craig Hallum Buy $15
Dec-18-24Initiated Maxim Group Buy $12
Nov-14-25 12:04AM
Nov-13-25 05:50PM
04:05PM
Nov-12-25 05:25PM
08:42AM
04:18PM Loading…
Nov-10-25 04:18PM
08:15AM
Nov-07-25 07:30AM
Nov-06-25 08:00PM
04:37PM
Nov-04-25 07:30AM
Nov-03-25 09:37PM
05:35PM
Oct-30-25 07:30AM
Sep-22-25 06:32AM
07:00AM Loading…
Sep-10-25 07:00AM
Sep-02-25 08:30AM
Aug-13-25 08:00AM
Aug-12-25 03:03AM
Aug-11-25 06:55PM
07:30AM
Aug-07-25 07:15PM
Aug-06-25 05:45PM
Aug-04-25 08:30AM
Jul-24-25 11:09AM
Jul-23-25 08:30AM
Jun-04-25 07:00AM
Jun-03-25 08:50AM
May-21-25 08:30AM
08:00AM
05:45PM Loading…
May-15-25 05:45PM
04:05PM
May-13-25 07:15AM
May-12-25 08:30AM
May-08-25 10:00AM
08:15AM
May-07-25 05:25PM
May-06-25 06:30PM
May-01-25 08:30AM
Apr-15-25 07:20AM
Apr-10-25 10:10AM
Mar-31-25 08:54PM
05:45PM
04:05PM
Mar-26-25 08:10AM
Mar-17-25 08:30AM
Mar-06-25 08:30AM
Mar-04-25 08:30AM
Feb-18-25 08:30AM
Feb-12-25 08:30AM
Jan-22-25 07:00AM
03:30AM
Jan-08-25 08:40AM
Dec-11-24 01:00AM
Dec-02-24 08:00AM
Nov-25-24 04:05PM
03:30AM
Nov-21-24 08:30AM
Nov-18-24 08:30AM
Nov-12-24 08:30AM
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.